Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the study details page remains consistent across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:19:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and version upgrade to v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:10:48.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:15:48.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated version from v3.0.1 to v3.0.2, indicating a minor update/patch. The Back to Top link was removed; no other substantive changes to core content, pricing, stock, or dates.
    Difference
    0.2%
    Check dated 2025-09-13T17:11:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T14:53:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations in Switzerland, as well as a revision update to version 3.0.0. Notably, terms related to renal cell carcinoma and various blood proteins have been added, while previous mentions of certain antineoplastic agents and location terms have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:40:18.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.